Chenfang Dong

4.2k total citations · 1 hit paper
57 papers, 3.0k citations indexed

About

Chenfang Dong is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Chenfang Dong has authored 57 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Nutrition and Dietetics. Recurrent topics in Chenfang Dong's work include Prion Diseases and Protein Misfolding (20 papers), Trace Elements in Health (14 papers) and Cancer Cells and Metastasis (12 papers). Chenfang Dong is often cited by papers focused on Prion Diseases and Protein Misfolding (20 papers), Trace Elements in Health (14 papers) and Cancer Cells and Metastasis (12 papers). Chenfang Dong collaborates with scholars based in China, United States and Taiwan. Chenfang Dong's co-authors include Binhua P. Zhou, Zhanyu Wang, Yadi Wu, Yiwei Lin, B. Mark Evers, Jun Yao, Yifan Wang, Piotr Rychahou, Tiebang Kang and Yinhua Yu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Chenfang Dong

52 papers receiving 2.9k citations

Hit Papers

Loss of FBP1 by Snail-Mediated Repression Provides Metabo... 2013 2026 2017 2021 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenfang Dong China 23 2.3k 1.0k 885 226 200 57 3.0k
Matthew G. Annis Canada 27 2.0k 0.9× 827 0.8× 835 0.9× 246 1.1× 223 1.1× 44 3.0k
Karim Bensaad United Kingdom 14 2.6k 1.1× 2.0k 2.0× 829 0.9× 240 1.1× 201 1.0× 18 3.7k
Susan E. Nozell United States 30 1.5k 0.6× 562 0.6× 791 0.9× 210 0.9× 141 0.7× 44 2.7k
Rossano Lattanzio Italy 29 1.3k 0.6× 436 0.4× 959 1.1× 138 0.6× 290 1.4× 83 2.7k
Andreas Marti Switzerland 20 2.0k 0.9× 389 0.4× 797 0.9× 219 1.0× 200 1.0× 30 2.8k
Sang-Oh Yoon United States 21 2.0k 0.9× 570 0.6× 584 0.7× 393 1.7× 152 0.8× 30 2.8k
Mingjing Xu Hong Kong 20 1.2k 0.5× 742 0.7× 507 0.6× 135 0.6× 244 1.2× 38 2.3k
Barbara Bedogni United States 27 1.5k 0.7× 552 0.5× 535 0.6× 254 1.1× 125 0.6× 46 2.3k
Xiaoli Wu China 30 1.8k 0.8× 741 0.7× 438 0.5× 167 0.7× 206 1.0× 82 2.8k
Ángeles Durán United States 29 2.5k 1.1× 1.0k 1.0× 880 1.0× 587 2.6× 251 1.3× 38 3.9k

Countries citing papers authored by Chenfang Dong

Since Specialization
Citations

This map shows the geographic impact of Chenfang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenfang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenfang Dong more than expected).

Fields of papers citing papers by Chenfang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenfang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenfang Dong. The network helps show where Chenfang Dong may publish in the future.

Co-authorship network of co-authors of Chenfang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Chenfang Dong. A scholar is included among the top collaborators of Chenfang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenfang Dong. Chenfang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xingyu, Ming Yi, Qianhua Cao, et al.. (2025). Acetylation suppresses breast cancer progression by sustaining CLYBL stability. Journal of Translational Medicine. 23(1). 415–415.
2.
Liao, Ruocen, et al.. (2025). RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization. Molecular Cancer. 24(1). 311–311.
3.
Liu, Ruiqi, Xiaodong Liang, H. Henry Guo, et al.. (2023). STNM1 in human cancers: role, function and potential therapy sensitizer. Cellular Signalling. 109. 110775–110775. 9 indexed citations
4.
Deng, Xinyue, Yinan Shen, Ming Yi, et al.. (2023). Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy. Journal of Medical Virology. 95(5). e28768–e28768. 15 indexed citations
5.
Liao, Ruocen, Xingyu Chen, Qianhua Cao, et al.. (2021). HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression. Frontiers in Oncology. 11. 780094–780094. 8 indexed citations
6.
Wang, Zhanyu, et al.. (2020). Metabolic reprogramming in triple-negative breast cancer. Cancer Biology and Medicine. 17(1). 44–59. 143 indexed citations
7.
Huang, Panpan, Ruocen Liao, Xingyu Chen, et al.. (2020). Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. Theranostics. 10(10). 4644–4658. 29 indexed citations
8.
Liao, Ruocen, Guoping Ren, Xingyu Chen, et al.. (2018). ME1 promotes basal-like breast cancer progression and associates with poor prognosis. Scientific Reports. 8(1). 16743–16743. 41 indexed citations
9.
Ye, Mingxiang, Yong Zhang, Hongjun Gao, et al.. (2017). Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling. Clinical Cancer Research. 24(5). 1227–1239. 59 indexed citations
10.
Wu, Xuebiao, Xiaoli Li, Qiang Fu, et al.. (2017). AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. The Journal of Experimental Medicine. 214(4). 1065–1079. 108 indexed citations
11.
Wu, Yadi, Yu Wang, Yiwei Lin, et al.. (2017). Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nature Communications. 8(1). 14228–14228. 115 indexed citations
12.
Dong, Chenfang, Tingting Yuan, Yadi Wu, et al.. (2013). Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer. Cancer Cell. 23(3). 316–331. 645 indexed citations breakdown →
13.
Dong, Chenfang, Yadi Wu, Jun Yao, et al.. (2012). G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. Journal of Clinical Investigation. 122(4). 1469–1486. 371 indexed citations
14.
Lin, Yiwei, Yadi Wu, Junlin Li, et al.. (2010). The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1. The EMBO Journal. 29(11). 1803–1816. 298 indexed citations
15.
Chen, Gao, Chen Wang, Jun Han, et al.. (2009). Molecular Epidemiological Study on Prevalence of Human Papillomaviruses in Patients with Common Warts in Beijing Area. Biomedical and Environmental Sciences. 22(1). 55–61. 9 indexed citations
16.
Li, Xiaoli, Chenfang Dong, Song Shi, et al.. (2009). The octarepeat region of hamster PrP (PrP51–91) enhances the formation of microtubule and antagonize Cu<sup>2+</sup>-induced microtubule-disrupting activity. Acta Biochimica et Biophysica Sinica. 41(11). 929–937. 5 indexed citations
17.
Chen, Jianming, Chen Gao, Qi Shi, et al.. (2008). Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Archives of Virology. 153(6). 1013–1020. 21 indexed citations
18.
Dong, Chenfang, Song Shi, Xiao‐Fan Wang, et al.. (2007). The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Archives of Biochemistry and Biophysics. 470(1). 83–92. 44 indexed citations
19.
Han, Jun, Chenfang Dong, Li Sun, et al.. (2007). Generation of genetic engineering monoclonal antibodies against prion protein. Medical Microbiology and Immunology. 196(4). 241–246. 2 indexed citations
20.
Dong, Chenfang, Xiao‐Fan Wang, Xin Wang, et al.. (2007). Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Medical Microbiology and Immunology. 197(4). 361–368. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026